338 filings
EFFECT
IMUX
Immunic Inc
1 May 24
Notice of effectiveness
12:15am
424B3
IMUX
Immunic Inc
30 Apr 24
Prospectus supplement
5:16pm
DEF 14A
IMUX
Immunic Inc
Definitive proxy
23 Apr 24
4:48pm
8-K
IMUX
Immunic Inc
8 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
S-3/A
IMUX
Immunic Inc
Shelf registration (amended)
1 Mar 24
4:09pm
8-K
r4pt vr5i8ng7j
22 Feb 24
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
6:35am
PRE 14A
17jxlil84alydl3
24 Jan 24
Preliminary proxy
5:05pm
D
c23 68r2uq1
19 Jan 24
Exempt offering of security
4:05pm
8-K
617dwo vk76ukb1
5 Jan 24
Immunic, Inc. Announces Private Placement of up to $240 Million
6:41am
8-K
ku0v7y pa
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
zrqvx 9u8k
14 Nov 23
Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:38am
8-K
yzdv6bam98ff62ue
18 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
15n eoqtjg
10 Oct 23
Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
8:48am
S-8
xj2uocr2kx6z
21 Aug 23
Registration of securities for employees
6:30am